PubHealth.info® (An Information Portal on Public Health Issues / Topics, Presented in Collaboration with PakMed Biomedical Solutions)

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]

Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.





YEAR: 1996




CATEGORY: Contraception (Birth Control) and Family Planning



TITLE



Risk of thromboembolic disease and oral contraceptive use. [Risque de

maladie thrombo-embolique et contraceptifs oraux.]



AUTHORS

Le MG


SOURCE

Contraception, Fertilite, Sexualite. 1996 May;24(5):378-83.



ABSTRACT

Four studies recently showed an increased risk of venous thromboembolic events (VTE) in current users of oral

contraceptives (OCs). This risk was higher in users of OCs containing third generation progestagens than in users of

OCs containing levonorgestrel. The excess of VTE attributable to the third generation pills should be about

10/100,000 woman-years. Conversely, the risk of death due to cardiovascular disease was not significantly

increased in users of third generation pills. In addition, the risk of myocardial infarction associated with these latter

types of pill was two-fold lower than the risk associated with the pills containing levonorgestrel, and this decrease

was of borderline significance (p = 0.10). The results of these different studies are described and discussed in this

paper. (summaries in ENG, FRE) (PubHealth.info Document ID: CONT2T 2076-06)



PubHealth.info NOTE: The author(s) of this article titled, "Risk of thromboembolic disease and oral contraceptive

use. [Risque de maladie thrombo-embolique et contraceptifs oraux.]", is(are) Le MG. The source of this article is

"Contraception, Fertilite, Sexualite. 1996 May;24(5):378-83.". This article was published in 1996 in French

language(s). (PubHealth.info® Document ID: CONT2T 2076-06. All rights reserved with PubHealth.info) PIN: 7076





 

 

Web

PubHealth.info

© Copyrights PubHealth.info®, an information portal on public health. All rights reserved.

This page is optimized to be viewed by Java script enabled Microsoft® Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels.